Core Viewpoint - Jiuan Medical (002432.SZ) forecasts a net profit attributable to shareholders of 2.02 billion to 2.35 billion yuan for the year 2025, representing a year-on-year growth of 21.05% to 40.83% [1] Financial Performance - The company expects a net profit excluding non-recurring gains and losses to be between 2.07 billion and 2.4 billion yuan, with a year-on-year increase of 23.18% to 42.81% [1] Business Drivers - The growth in net profit compared to the same period last year is primarily attributed to the strong performance of asset management business in major asset allocation [1] - The company remains committed to asset preservation and value enhancement while continuously improving risk resistance capabilities [1] Product Demand - Demand for the company's reagent kits, which serve as regular home screening tools for respiratory viruses, and home healthcare electronic products remains stable [1]
九安医疗(002432.SZ)发预增,预计2025年度归母净利润20.2亿元至23.5亿元,增长21.05%至40.83%